AQR Capital Management’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.08M | Buy |
491,611
+139,475
| +40% | +$2.01M | 0.01% | 1106 |
|
|
2025
Q1 | $2.43M | Buy |
352,136
+329,425
| +1,451% | +$2.27M | ﹤0.01% | 1504 |
|
|
2024
Q4 | $120K | Buy |
22,711
+3,075
| +16% | +$16.3K | ﹤0.01% | 2746 |
|
|
2024
Q3 | $71.7K | Buy |
+19,636
| New | +$71.7K | ﹤0.01% | 2684 |
|
|
2022
Q4 | – | Sell |
-76,571
| Closed | -$94K | – | 2297 |
|
|
2022
Q3 | $94K | Sell |
76,571
-156,232
| -67% | -$192K | ﹤0.01% | 2111 |
|
|
2022
Q2 | $389K | Sell |
232,803
-180,986
| -44% | -$302K | ﹤0.01% | 1766 |
|
|
2022
Q1 | $1.02M | Buy |
413,789
+181,358
| +78% | +$446K | ﹤0.01% | 1523 |
|
|
2021
Q4 | $869K | Buy |
232,431
+60,590
| +35% | +$227K | ﹤0.01% | 1617 |
|
|
2021
Q3 | $1.08M | Buy |
171,841
+55,854
| +48% | +$350K | ﹤0.01% | 1496 |
|
|
2021
Q2 | $1.14M | Buy |
115,987
+38,650
| +50% | +$381K | ﹤0.01% | 1524 |
|
|
2021
Q1 | $722K | Sell |
77,337
-81,559
| -51% | -$761K | ﹤0.01% | 1691 |
|
|
2020
Q4 | $763K | Buy |
158,896
+17,695
| +13% | +$85K | ﹤0.01% | 1616 |
|
|
2020
Q3 | $566K | Buy |
+141,201
| New | +$566K | ﹤0.01% | 1663 |
|
|
2019
Q4 | – | Sell |
-23,024
| Closed | -$91K | – | 2188 |
|
|
2019
Q3 | $91K | Buy |
+23,024
| New | +$91K | ﹤0.01% | 2081 |
|